These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2222775)

  • 1. Hydatidiform mole pregnancy trophoblast extracts differentially suppress interleukin-2-induced proliferation of human T-lymphocytes and PHA-blasts.
    Bennett WA; Brackin MN; McGehee RP; Cowan BD
    Am J Reprod Immunol; 1990 Jun; 23(2):44-9. PubMed ID: 2222775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational age correlates with immunosuppressive properties of hydatidiform mole pregnancies.
    Bennett WA; Long CA; McGehee RP; Cowan BD
    Am J Reprod Immunol; 1994 Oct; 32(3):163-6. PubMed ID: 7880398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunosuppressive properties of hydatidiform mole decidua and trophoblast extracts.
    Bennett WA; Brackin MN; Long CA; Cowan BD
    Am J Reprod Immunol; 1996 Aug; 36(2):86-9. PubMed ID: 8862251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydatidiform mole macromolecules inhibit interleukin-2-mediated murine lymphocyte proliferation in vitro.
    Bennett WA; Ellsaesser CF; Cowan BD
    Am J Reprod Immunol Microbiol; 1988 Nov; 18(3):76-80. PubMed ID: 3265597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of lymphocyte proliferation in vitro by macromolecules in the vesicle fluid and tissue extracts of hydatidiform mole.
    Cowan BD; Bennett WA; Brackin MN; McGehee RP
    J Reprod Immunol; 1989 Mar; 15(1):39-49. PubMed ID: 2715981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by hydatidiform mole trophoblast is neutralized by monoclonal antibodies to beta-interferon.
    Bennett WA; Brackin MN; Long CA; Cowan BD
    Am J Reprod Immunol; 1994 Oct; 32(3):157-62. PubMed ID: 7880397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells.
    Chien EJ; Chang CP; Lee WF; Su TH; Wu CH
    J Cell Biochem; 2006 Sep; 99(1):292-304. PubMed ID: 16619256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
    Bruserud O; Pawelec G
    Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
    Vine JB; Geppert TD; Lipsky PE
    J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression.
    Yang SX; Xie SS; Gao HL; Ma DL; Long ZZ
    Int J Immunopharmacol; 1994 Nov; 16(11):895-904. PubMed ID: 7868294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decidual T lymphocyte activation in hydatidiform mole.
    Wongweragiat S; Searle RF; Bulmer JN
    J Clin Pathol; 1999 Dec; 52(12):888-94. PubMed ID: 10711251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of monoclonal antibodies directed against lymphocyte markers with trophoblast cells of normal placenta, hydatidiform mole, and gestational choriocarcinoma.
    Berkowitz RS; Umpierre SA; Goldstein DP; Anderson DJ
    Gynecol Oncol; 1988 Jan; 29(1):94-100. PubMed ID: 2828198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC; Davis LS; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
    Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
    Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).
    Rigby WF; Stacy T; Fanger MW
    J Clin Invest; 1984 Oct; 74(4):1451-5. PubMed ID: 6332829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that 8-methoxypsoralen (8-MOP) is a T-lymphocyte immunomodulatory agent.
    Cox GW; Orosz CG; Lewis MG; Olsen RG; Fertel RH
    Int J Immunopharmacol; 1988; 10(6):773-81. PubMed ID: 3264275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.
    Warren HS; Bezos A
    Immunology; 1987 Jun; 61(2):167-72. PubMed ID: 3496271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
    Katzen D; Chu E; Terhost C; Leung DY; Gesner M; Miller RA; Geha RS
    J Immunol; 1985 Sep; 135(3):1840-5. PubMed ID: 3926887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.